|Venture Round, 5/07 |
Ann Arbor SPARK
SensiGen is a biotechnology company focused on gene-based molecular diagnostics. Their mission is to develop and commercialize nucleic acid tests that detect serious diseases earlier, monitor diseases more effectively, and lower overall healthcare costs. The Company has a late stage pipeline of high value diagnostic tests for cervical cancer, head & neck cancer, chronic kidney disease and lupus, all of which address very large markets with significant unmet needs.